Preferred Label : Skin Test;
NCIt definition : A preparation of an antigenic component of an infectious agent that is administered
to a patient in order to determine whether previous exposure to the agent has occurred,
and/or to assess the integrity of the patient's cellular immune system. Depending
on the clinical situation, the appearance of a delayed (cellular) hypersensitivity
response, which manifests as an area of induration and erythema at the injection site,
i.e. a positive test result, may indicate previous exposure to a particular infectious
agent. (NCI04);
Alternative definition : NCI-GLOSS: A test for an immune response to a compound by placing it on or under the
skin.;
Codes from synonyms : CDR0000045881;
Origin ID : C17137;
UMLS CUI : C0037296;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
- skin test [Artificial nutrition thesaurus concept]
Semantic type(s)
UMLS correspondences (same concept)
concept_is_in_subset
https://www.cancer.fr/catalogue-des-publications/patients-atteints-d-un-melanome-cutane-ou-muqueux-indications-des-tests-moleculaires-en-vue-de-la-prescription-de-traitements-de-precision
https://www.cancer.fr/catalogue-des-publications/synthese-patients-atteints-d-un-melanome-cutane-ou-muqueux-indication-des-tests-moleculaires-en-vue-de-la-prescription-de-traitements-de-precision
2023
false
false
false
France
practice guideline
Trait
skin test, nos
During Treatment
Treating
Accuracy
Regardless
Analytical Procedure Accuracy
indication of
melanoma, cutaneous malignant
prescription, nos
Analytical Procedure Precision
Chronic Villitis
skin tests
Patient
Unspecified
Therapy Object
vision, ocular
patients
Skin Test
On Treatment
No Treatment for Diabetes
mucous membrane, nos
Off-Label use
Cutaneous Melanoma
Tray
Sight
Treatment Study
Treat
Mucosal Melanoma
Molecular
suggestive of
Treatment
Treatment Epoch
has patient
Biomaterial Treatment
disease
Tray Dosing Unit
melanoma
mucous membrane
Prescription
GDC Treatment Frequency Terminology
---